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Abstract
The bacterial challenge on the periodontal tissues triggers an inflammatory reac-
tion, driven by pro-inflammatory cytokines, that eventually leads to the periodontal 
structures’ damage. The pathogenic mechanisms of this inflammatory reaction are 
complex and are influenced by the type of host-immune response and certain local 
and systemic factors. These factors can influence periodontal inflammation, through 
the action of the various pro-inflammatory cytokines. Periodontal disease and certain 
systemic conditions can have a mutual association, as the pathogenic mechanisms 
of these diseases can involve similar molecular and cellular elements. The concept of 
‘periodontal medicine’ comprises these pathogenic connections, focusing on the key 
role that periodontal health has on the general homeostasis and well-being.
Keywords: periodontal disease, cytokines, inflammation, systemic conditions, 
associations
1. Introduction
Periodontal disease is defined as an immune, inflammatory disease with a 
triggering bacterial factor [1]. Its initial phase is characterised by damage to soft 
gingival tissue (inflammation of gums, gingivitis, plaque accumulation), fol-
lowed by degradation of the periodontium (chronic inflammation, colonisation by 
periodontal pathogenic anaerobes) and the surrounding connective tissue matrix of 
teeth, along with alveolar bone loss, local citrullination, bone resorption and rapid 
loss of teeth, in the destructive phase [2].
It is considered a multifactorial disease with progressive evolution and patho-
physiological mechanisms that involve the association of environmental factors 
(smoking, stress), microbial factors (several bacterial species, for example, 
Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Aggregatibacter 
actinomycetemcimtans), and genetic polymorphism (human leukocyte antigen-
antigen D, HLA-DR, HLA-DRB1; IL-1, IL-6 and IL-10 gene polymorphism) with 
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the inflammatory and immune response (both innate and adaptive immunity) of 
the host (Table 1) [3, 4]. These mechanisms will lead to defective host defences, 
which will contribute to changes in tissue homeostasis, inflammation and bone loss, 
the main features of periodontal disease (Figure 1) [2].
General 
function
Type Specific function Periodontal implication
Pro-
inflammatory
IL-1β Increases production of other 
pro-inflammatory mediators (PGE2, 
IL-6); stimulates neutrophil activity
Key role in the pathogenic 
processes; enhances alveolar 
bone-resorption; fuels the 
inflammatory reaction
IL-1α ‘Alarmin’ for tissue damage and 
immune system; interacts with 
TNF-α; induces protease synthesis
Enhances alveolar bone-
resorption by signalling 
the presence of bacterial 
antigens and enhancing the 
inflammatory response
IL-6 Regulates cell growth and 
differentiation: osteoblasts, B and T 
lymphocytes
Impairs osteoblast growth and 
function; increases osteoclast 
formation from monocytes
IL-18 Increases neutrophil activity and 
interferon gamma production
Influences lymphocyte Th1/
Th2 differentiation; interacts 
with IL-1β
IL-33 Activates Th2 and mast cells; 
stimulates production of IL-5, IL-13 
by Th2 cells
Induction of RANKL; induces 
periodontal damage by 
stimulation of Th2 cells
TNF-α Major regulator of immune cells’ 
activity; involved in the acute phase 
reaction
Stimulates damage (by 
osteoclasts) and prevents repair 
of periodontal tissues (by 
fibroblast death); starts IL-1β, 
PGE2 synthesis
PGE2 Increases production of other pro-
inflammatory mediators (MMPs); 
induces fever
Contributes to bone resorption 
by increasing osteoclast activity
MMPs 
(-1, -8, 
-9)
Enzymatic degradation of collagen 
(and other extra-cellular matrix 
proteins). Stimulated by IL-1β and 
TNF-α. Influences immune cell 
migration and adhesion
Periodontal damage by 
impairment of collagen type 
I production and degradation 
of structural collagen; causes 
activation of osteoclasts and 
damage to connective tissue
Anti-
inflammatory
IL-1Ra Inhibits IL-1β, IL-1α activity by 
preventing cellular signalling
Limits alveolar bone-
resorption; regulates response 
to antigens (LPS)
IL-10 Decreases cytokine production by 
immune cells; reduces inflammatory 
response
Down-regulates periodontal 
inflammation by reducing 
cytokine synthesis in immune 
cells
IL-4 Stimulates tissue repair and 
regulates immunity; regulates 
differentiation of Th2 cells
Decreases production of 
Th2 cells, with important 
implications to periodontal 
damage
TGF-β Enhances epithelial regeneration/
repair
Stimulates gingival fibroblast 
activity
Table 1. 
Mediators’ role in general and periodontal inflammatory reactions [3].
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Pathophysiological processes are explained by the participation of a wide range 
of locally released soluble factors such as pro-inflammatory cytokines, prostaglan-
din E2 and reactive oxygen species, inflammatory mediators that can be highlighted 
by various methods within gingival tissues and within the gingival crevicular fluid 
(GCF) [5]. The association between elevated TNF-α and IL-6 concentrations and 
disease activity was also highlighted [6]. It has been shown that IL-1β and inter-
feron-gamma (IFN-γ) have elevated concentrations in active periodontal lesions 
[7]. IL-12, a key-acting cytokine mediating Th1 differentiation, also implicated in 
cell-mediated immunity, has been observed to stimulate pro-inflammatory proteins 
involved in bone resorption [8].
A deficiency in the synthesis and release of anti-inflammatory cytokines can also 
occur, like type Th2 cytokines (IL-4, IL-5, IL-13), IL-10 and transforming growth 
factor beta 1 (TGF-β1), which confirms the existence of an imbalance between 
pro- and anti-inflammatory mechanisms at periodontal level [9]. Along with TNF-α, 
IL-1β and IL-6, the release of the cytokines IL-8, IL-11, and IL-17 has also been 
revealed within GCF, which has potent osteoclastogenesis stimulating effects and 
also reduces osteoprotegerin synthesis in osteoblasts and stromal cells [10].
Periodontal disease can be influenced by certain local factors, such as orth-
odontic therapy and the existence of coronal or prosthodontic restorations, and 
by certain systemic diseases, this may interfere with the periodontal inflammatory 
reaction, by means of pro-inflammatory cytokines. These diseases include diabetes 
mellitus (type 1 and 2), cardiovascular diseases, rheumatoid arthritis and hepatic 
and renal conditions. The interactions between periodontal tissues and their pathol-
ogy and these systemic diseases have been reunited under the concept of ‘periodon-
tal medicine’ [11]. Considering this concept, the chapter aims to exhibit the major 
implications of cytokines into the pathogenic mechanisms of periodontal disease 
and its local and systemic influencing factors.
2. Methodology
The design of the chapter has been created in order to reflect the role of cyto-
kines in periodontal pathogenic processes, as both local and systemic risk factors for 
Figure 1. 
The periodontium and its inflammatory reaction in periodontal disease: a—bacterial plaque deposits;  
b—gingival sulcus; c—inflammatory mediators (interleukins—ILs, matrix-metalloproteinases—MMPs, tissue 
inhibitors of MMP—TIMPs); d—lymphocytes type B and T; e—polymorphonuclear cells; f—blood vessel;  
g—macrophage cells; h—osteoclast cells; i—gingival epithelium; j—periodontal ligament; k—gingival 
connective tissue; and l—alveolar bone.
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periodontal disease have been taken into consideration. The information is divided 
between the influence of local elements—orthodontic and restorative treatments, 
and systemic ones—diabetes mellitus type 1 and 2, cardiovascular, rheumatic, 
hepatic and renal diseases. Relevant scientific information has been sourced from 
the existing scientific literature and structured so as to pursue the established 
purpose of the chapter.
3. Local influences on the periodontal inflammatory reaction
3.1 Orthodontic influences
The orthodontic dental movement is the consequence of the application of 
controlled mechanical forces on the teeth [12], the periodontal ligament (PDL) 
being the one that mediates the task to which the teeth and the alveolar bone are 
subjected and creates the conditions for the cells to participate in bone remodel-
ling [13]. Orthodontic forces distort the PDL matrix, causing the cellular form and 
cytoskeleton configuration to change, with neuropeptides release from the afferent 
nerve terminals [14], while the orthodontic forces can induce a biomolecular-level 
release of growth factors, prostaglandins and pro-inflammatory cytokines as IL-1, 
IL-6, IL-8 and TNF-α, that affect alveolar bone remodelling [15]. At present, the 
molecular mechanisms underlying bone formation, induced by stretching forces, 
are not fully understood [16]. The initial phase of orthodontic dental movement 
always involves an aseptic acute inflammatory reaction [17], which lasts for 1–2 days 
and is predominantly exudative, followed by a chronic, mainly proliferative process 
[18] and increased release of cytokines [19], such as TNF-α, TNF-β, IL-1, PDGF, 
INF-γ and RANKL [15, 20].
Inflammatory cytokines are involved in all phases of inflammation during 
orthodontic treatment [21]; pro-inflammatory and anti-inflammatory cytokines act 
synergistically or antagonistically on each other [22]:
• IL1 family: all 3 ligands of the IL-1 family (IL-1α, IL-1β, and IL-1RA) are 
involved in bone metabolism and orthodontic dental movement [22], as well as 
IL-1 gene polymorphisms [23]. IL-1β along with TNF-α is a key pro-inflamma-
tory cytokine in acute-phase inflammation [24]. IL-1β gathers leukocytes and 
activates fibroblasts, endothelial cells, osteoclasts and osteoblasts in order to 
stimulate bone resorption and to stop bone formation [25]. IL-1β is also a PGE 
inducer and, along with mechanical stress, synergistically regulates the forma-
tion of PGs in periodontal cells [26]. The levels of IL-1β and PGE2 are higher in 
the tension zones compared to compression zones, which supports the hypoth-
esis that during the initial stage of orthodontic treatment, this cytokine would 
originate from osteoclasts in response to mechanical stress [27].
• IL-1RA acts by limiting the inflammatory conditions [28] mediated by IL-1 
and bone resorption [22], and therefore positive correlations exist between 
decreasing IL-1RA levels in GCF and faster bone resorption during orthodon-
tic dental movement and consequently a higher dental movement speed [29].
The tooth movement speed is influenced by stress and by levels of IL-1RA, 
IL-1β and IL-1 gene polymorphisms from GCF. These factors provide a bet-
ter predictive model for the efficiency of dental movement: activity index 
[AI = experimental (IL-1β/IL-1RA)/control (IL-1β/IL-1RA)], IL-1RA concen-
tration in GCF and IL-1β genotype [29].
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• IL6: IL-6 has a stimulating effect on bone remodelling and osteoclast formation [30] 
and also in the inflammation associated with orthodontic dental movement [31].
• IL8: IL-8 has a role in the neutrophils’ recruitment and activation in the pres-
ence of inflammation [32], in improving RANKL expression and consequently 
in increasing the osteoclast production and their activation [33]. Immediately 
after the application of mechanical forces, IL-8 has an increased level in both 
pressure and tension zones [34], but later on, the stimulation of IL-8 secretion 
only continues in the tension zones; this differential regulation probably plays 
a major role in the initial stage of bone remodelling [34].
• TNF-α: TNF-α binds with macrophage colony-stimulating factors to induce 
osteoclast differentiation [35].
• IFN-γ: IFN-γ increases during late stages of orthodontic dental movement [35], 
controlling massive osteoclastogenesis [36] related to the increased volume of 
trabecular bone [37].
The levels of cytokines in the GCF vary with the type and intensity of the applied 
force, speed of tooth movement, the age of the orthodontic device owner [24] and 
growth [38]. Equivalent force systems during orthodontic dental movement induce 
an individualised production of different cytokines [39]. Light continuous forces 
tend to maintain relatively high levels of IL-1β [29], needed for the continuation of 
periodontal remodelling, longer periods allowing a reduced frequency of reactiva-
tions [38]. A strong force may increase the risk of root resorption and hyalinization 
of PDL and may also modify the cytokines’ level, causing unwanted tissue reactions 
and the need for multiple reactivations [40]. The increase of IL-1β’s level in GCF, as 
a result of the increased applied force, was also associated with intense pain during 
orthodontic dental movement [38], probably due to the correlation between IL-1β 
and substance P [41]. Most studies did not detect differences between the levels of 
cytokines in the tension and pressure zones [29, 34], probably due to the continuous 
circulation of GCF in the periodontal ligament. Consequently, it can be concluded 
that GCF cytokine levels cannot be specific indicators of periodontal remodelling in 
tension and pressure zones [42].
External apical root resorption (EARR), secondary to orthodontic dental 
movement, is a frequent clinical complication, and treatment variables, environ-
ment factors and/or inter-individual genetic variations may give susceptibility or 
resistance to its occurrence [43]. Among pro-resorptive cytokines, IL-6 promotes 
osteoclastic function [44] and amplifies the production of fibroblasts from gingival 
fluid and periodontium [45], having increased levels in patients with severe dental 
root resorption [46]. IL-7 acts indirectly on osteoclastogenesis by induction of 
TNF-α [47]. The increase of IL-6, IL-7 and TNF-α level might be a sign of a continu-
ous remodelling of the periodontal tissues during the lag phase of tooth movement 
and a mechanism of cellular prohibition [48].
Regarding anti-resorptive cytokines, the levels of IL-4 and IFN-γ increase 
closely following IL-1β’s elevation. This cytokine’s expression type may result 
as an active combined remodelling of periodontal tissue, during the first stages 
of dental movement and also of cellular prohibition mechanisms, preventing 
activation and additional differentiation of osteoclastic cells [48] and suppressing 
osteoclastogenesis, unlike T cells of RANKL that induce osteoclastogenesis [49]. 
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is also an anti-
resorptive cytokine that prevents bone resorption together with IL-4, IL-10, IL-13, 
IL-18 and IFN-γ [50].
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3.2 Restorative influences
The interplay between periodontology and restorative dentistry exists on 
many levels and functions, in both directions [51]. For example, interproximal 
restorations, fixed prosthesis and artificial crowns can be involved in the occur-
rence and progression of gingival inflammation and periodontal destruction [51]. 
The presence of dental restorations or other appliance, near or below the gingival 
margin, which reach deep into the gingival sulcus or within the junctional epi-
thelium, may induce localised inflammation that could lead to future periodontal 
complications [51].
The most reliable mechanism by which the subgingival margins of restora-
tions lead to gingival inflammation and loss of attachment is the increase of 
plaque accumulation. In these conditions, the rate flow of gingival fluid will 
increase, because the gingival fluid protects oral tissues (including the junctional 
epithelium) against the bacterial invasion, acting as a defensive barrier, within 
the gingival sulcus [52]. IL-1, prostaglandin E2 (PGE2) and the elements that 
affect collagen and bone (matrix metalloproteinases (MMPs)) that are detected 
in gingival fluid can be used as possible indicators for the diagnosis of periodon-
tal disease and its progression [2]. The placement of restorative posts can induce 
trauma to periodontal structures, mostly in the case of metallic posts and less for 
the fibre ones, leading to periodontal inflammation [53]. IL-1 family cytokines 
regulate the activity of other pro-inflammatory cytokines, such as PGE2 and 
MMPs, their gingival fluid levels being proportionate with the degree of bone 
loss [10].
The placement of the gingival margins of restorations depends on the posi-
tion of the decayed portion of the tooth and the extent of caries. The materials 
used in restorations must not be injurious to periodontal tissues, as they should 
have highly polished surfaces, the periodontium reacting to the roughness of the 
material and its accumulation of plaque by inflammation. However, it has been 
shown that the composition of restorative materials could also initiate periodon-
tal changes, by monocyte activation and changes of the gingival fluid levels of 
cytokines [54]. It has been observed that periodontal inflammation can occur in 
areas of the gingival tissue which are adjacent to ceramic, composite or amalgam 
coronal restorations, even if there are no signs of bacterial plaque accumulation. 
This may be explained by the stimulation of periodontal neurogenic inflamma-
tory reactions that is caused by these restorative materials. However, these find-
ings are controversial and require further research, as it has been reported that 
only class V composite fillings can trigger such forms of gingival inflammation, in 
the areas of their vicinity [55].
Ceramic materials have the lowest plaque retentive capacity, but inner materials 
of porcelain-fused-to-metal (PFM) crowns can impact periodontal tissues [56]. 
Certain non-noble metals could have a negative impact on periodontal tissue (Ni-Cr 
alloy, Co-Cr alloy). It seems that the Au-Pt alloy is least harmful for the periodon-
tium. The spaces between the margins of the restoration, as well as their contour are 
other contributing factors to gingival inflammation and periodontal destruction, 
referred to as iatrogenic factors. Restoration margins have been reported as key 
factors for periodontal health [57]. Another feature referring to periodontal damage 
is the dental impression that needs to offer a clear image and perspective of the pre-
pared teeth, the neighbouring teeth and the associated gingival tissue. Impressions 
of tooth preparations with an elastic material that extends subgingivally could 
damage soft tissues. In order to prevent this, the retraction cord is frequently used 
during impression taking [58]. Successful restorative and prosthetic treatments 
require a healthy periodontium, as a start point of therapeutic protocols [51].
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4.  Systemic pathologic influences on the periodontal inflammatory 
reaction
4.1 Type 2 diabetes
The relationship between type 2 diabetes mellitus (T2DM) and chronic peri-
odontitis is bidirectional [59]. The deleterious effect of chronic hyperglycemia 
on the occurrence and progression of periodontitis has been observed in patients 
suffering from both diseases [59]. Among the factors involved in the pathogenesis 
of periodontitis in patients with T2DM are the advanced glycation end products, 
chronic inflammation, altered secretion profile of cytokines, decrease of the 
immune response to infection and also the exacerbation of bacterial flora at peri-
odontal level [59].
Recent evidence has suggested the role of periodontitis in the pathogenesis of 
insulin resistance, the adverse effects of periodontitis on glycemic control, and the 
contribution to the occurrence and progression of chronic diabetic complications 
[60]. The link between periodontitis and T2DM is potentially explained by the 
increase of pro-inflammatory cytokines, such as IL-1β, IL-8, IL-6, TNF-α, IL-12, 
and leptin and decrease of anti-inflammatory cytokines such as IL-4, IL-11, adipo-
nectin and fibroblast growth factor-21 [60, 61].
The assessment of cytokine levels within the gingival crevicular fluid indicated 
that subjects with T2DM and chronic periodontal disease have significantly higher 
levels of IL-1β, IL-6 and TNF-α than healthy participants with similar periodontal 
conditions [59]. The levels of IL-8 within the gingival crevicular fluid and plasma 
have been evaluated with contradictory results in the context of T2DM and chronic 
periodontitis, multiple studies reporting that the IL-8 level is higher in patients with 
T2DM and chronic periodontitis compared to non-diabetic subjects with or without 
chronic periodontitis [60, 62].
The systemic inflammatory response depends on the ratios of pro-inflammatory 
to anti-inflammatory cytokines. The patients with T2DM and chronic periodontitis 
tend to have higher ratios of pro-inflammatory to anti-inflammatory cytokines 
compared to periodontally and systemically healthy controls [63]. Thus, TNF-α/
IL-4, IL-1β/IL-4, IL-23/IL-4, IL-6/IL-4, TNF-α/IL-5, IL-17/IL-5 and IL-6/IL-5 ratios 
were higher in T2DM patients with chronic periodontitis than in healthy subjects 
[64].
The literature regarding the systemic plasma cytokine profile’s characteristics 
in patients with T2DM and chronic periodontitis is not consistent. Some reports 
indicated lower levels of cytokines, including IL-4, IL-5, IL-6, TNF-α, IL-1β, IL-17, 
IL-13, IFN-γ, IL-2, IL-23 and IL-12 and higher levels of IL-8 in serum samples of 
T2DM patients with chronic periodontitis than for the control group [60, 63]. There 
are other studies showing that the systemic levels of some cytokines, such as IL-4, 
IL-8, IL-6, IL-10 and TNF-α, did not differ between diabetic and non-diabetic 
subjects with periodontitis [62, 64].
The improvement of glycemic control after periodontal therapy may be 
explained by the fact that periodontal treatment relives the periodontal inflam-
matory reaction and further decreases systemic pro-inflammatory cytokines’ 
involvement in the pathogenesis of insulin resistance [65]. Reduction of the pro-
inflammatory cytokines such as IL-1β and IL-6 in gingival crevicular fluid and 
improvement of glycemic control after periodontal therapy was reported in T2DM 
patients [66]. Furthermore, a significant decrease in serum levels of IL-6 and 
TNF-α and also a reduction of HbA1c in patients with T2DM were reported after 
periodontal therapy, indicating the impact of periodontal intervention on periodon-
tal and systemic inflammation related to insulin resistance [65, 66]. Recent findings 
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show that reducing periodontal inflammation by periodontal therapy may contrib-
ute to an increase of systemic anti-inflammatory cytokines, such as adiponectin and 
fibroblast growth factor-21 levels, and to a decrease of leptin levels, thus improving 
insulin sensitivity [65].
As high levels of pro-inflammatory cytokines have been reported at periodontal 
level, associated with increased risk of destructive effects within the periodontal 
tissues [67], it was shown that diseases characterised by insulin resistance like T2DM 
are also associated with the increase of cytokines [68, 69]. Chronic periodontitis may 
influence systemic cytokines in T2DM. The literature documents the role of cyto-
kines TNF-α, IL-1β, IL-4, IL-6 and IL-10 in chronic periodontitis and T2DM [70].
Pathogenic links between periodontal disease and diabetes involve elevations in 
IL-1β [71], TNF-α, IL-6, RANKL-b, oxidative stress and Toll-like receptor (TLR) 
expression. It has been demonstrated that prolific circulatory mediators have higher 
levels in the association of diabetes with a form of periodontal disease, especially 
TNF-α, C-reactive protein (CRP) and mediators of oxidative stress, which in turn 
can affect the control of diabetes. Moreover, complete and correct periodontal 
treatment can improve serum levels of CRP and TNF-α in patients affected by 
diabetes [65, 72].
The release of inflammatory mediators that can be detected in GCF stimulates 
the secretion of metalloproteinases, initiates bone resorption processes and plays an 
important role in the evolution and prognosis of periodontal disease. Inflammatory 
cytokine and chemokine levels in GCF decreased after initial periodontal therapy 
[73]. In periodontitis, concentrations of pro-inflammatory cytokines TNF-α and 
IL-8 increased not only in periodontal tissues [74] but also in serum samples [62].
4.2 Type 1 diabetes
The existence of a bidirectional relationship between periodontal disease and 
type one diabetes (T1D) has long been considered [75]. Periodontal breakdown is a 
pivotal aggravating factor for the health status in subjects with T1D, mainly because 
this preserves a chronic systemic inflammatory condition, contributing therefore 
to diabetic complications [75]. In fact, periodontitis has been considered to be the 
sixth complication of diabetic disease, diabetic metabolic impairment being in turn 
able to point toward a poor periodontal health status. Being not only a metabolic 
misbalance, but also tightly associated to an important dysfunction of the immune 
system, several facets of the systemic immune response, such as antigen challenge 
or polymorphonuclear leukocyte and T-lymphocyte function are altered in diabetic 
subjects [76].
Hyperglycemia can lead to immune system disorders; hence, the effects medi-
ated by cytokine alterations in patients with T1D might be significant. IL-1β levels 
in gingival fluid and those of IL-6 in saliva have been correlated with glycosylated 
haemoglobin [77]. The changes in the cytokine amount on the systemic level are 
crucial in the pathogenesis of diabetes and can condition the islet cell turnover and 
apoptosis, with subsequent disease progression toward devastating complications, 
as macro- and microvascular modifications [78].
Regarding the involvement of cytokines in the immune-inflammatory response 
in subjects with T1D and periodontal breakdown, the literature highlights the 
enhancement of IL-1β, IL-6 and prostaglandin E2 in the gingival fluid of these 
patients, compared to systemically healthy subjects, with comparable periodontal 
alteration [79, 80]. The results on experimental murine models of induced diabetes 
include data on a broader range of mediators: IFN (interferon), chemokines such 
as macrophage inhibiting protein (MIP-2) and monocyte chemo-attractant protein 
(MCP-1), most likely mediated via TNF-α [81].
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The importance of TNF for enhancing the immune response, generated by 
bacterial plaque challenge, in T1D and T2D, has been experimentally shown for 
murine models with chronic periodontitis, but without a clear relation between the 
TNF-α levels found in oral tissues and those found in oral fluids of T2D periodontal 
subjects [81]. Along with these pro-inflammatory mediators, research has also been 
carried upon chemokines’ performance, growth factors and soluble adhesion mol-
ecules, which possess immune-regulatory capacity [79]. The simultaneous action of 
multiple mediators in evaluating oral immune response in periodontal patients with 
T1D has also been assessed [82].
Monocytes can have a hyper-inflammatory phenotype in patients with T1D, and 
these cells are susceptible to the action of lipopolysaccharides (LPS) of the peri-
odontal bacteria, and respond through generation of increased amounts of IL-1β, 
TNF-α and PGE2, compared to non-diabetic subjects [79]. This inflammatory 
phenotype of monocytes represents one of the relevant links between periodontal 
pathogenesis and diabetes mellitus [79].
Research on other cell populations involved in mediating the immune response 
advocates that T cells accumulation around insulin-sensitive cells is important in 
metabolic changes correlated to diabetes, via their capacity to moderate macrophage 
activity [83]. There are a number of distinct subclasses of T cells, with remark-
able plasticity, their role being strongly correlated to the local cytokine amount. 
However, although important in maintaining the Th1/Th2 cell balance in the 
pathogenesis and progression of periodontitis, data on the underlying mechanisms 
and their role in homeostasis of periodontal status in patients with diabetes are still 
to be elucidated [76].
Gathering the whole data related to the modulation of locally expressed media-
tors, the T1D-periodontitis association would be of particular relevance in the cura-
tive management plan, through conduction of long-term studies. Further research 
is necessary to better understand the cytokine expression in periodontal disease and 
type 1 diabetes.
4.3 Cardiovascular diseases
Cardiovascular disease (CVD) constitutes an extensive cluster of conditions that 
deter the physiological function of the heart and/or blood vessels and includes (a) 
coronary heart disease—angina/myocardial infarction; (b) ischaemic cerebrovas-
cular disease—transient ischaemic attack—TIA and (c) peripheral vascular disease. 
In both cardiovascular disease and periodontal disease, a systemic inflammatory 
overload is present in the organism, which can be exacerbated by factors such as 
smoking, obesity or diabetes mellitus that eventually leads to an altered dishomeo-
static status [84]. Due to the ulceration and inflammation of subgingival epithelial 
layer, oral pathogens and their by-products can access the blood stream, increasing 
the risk and aggravating the evolution of any pre-existing heart disease [85].
Atherosclerosis is commenced by deterioration of the endothelial tissue of 
vessels. Following impairment, endothelial pro-inflammatory signals drive not 
only the expression of adhesion molecules such as E-selectin, ICAM-1, P-selectin 
and VCAM-1, but also of IL-8 and thrombin that act as chemoattractants and 
determine an upsurge in the aggregation of platelets and migration of leukocytes 
[86]. Furthermore, these pro-inflammatory signals trigger the proliferation of 
smooth muscle cells and the apoptosis of endothelial cells. In this context of 
complex interactions, leukocytes migrate to the injured site and release additional 
pro-inflammatory cytokines (IL-1α and β, IL-6, IL-17, IL-22 and TNF-α), reactive 
oxygen species, as well as proteinases that break down the extracellular matrix of 
the endothelium [87].
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High concentrations of low-density lipoproteins (LDL) in plasma accumulate 
in the aortic wall beneath the intima layer of the endothelium and are oxidated into 
oxLDL. Increased blood pressure activates endothelial cells which advocate the 
activation of adhesion molecules that favour the migration of monocytes. In the 
aortic wall, these cells transform into macrophages that absorb the oxidated LDL 
and develop into foam cells filled with lipids. This circumstance further promotes 
the dispersion of pro-inflammatory molecules which stimulate the invasion and 
activation of supplementary inflammatory cells and facilitate their confinement in 
the plaque, precipitating subsequent build-up of inflammation factors [88].
Periodontal microorganisms can alter the mentioned mechanisms by virtue of a 
direct interaction (for example by the invasion of endothelial, smooth muscle cells, 
leukocytes and platelets), but also an indirect interplay by stimulating the release of 
paracrine factors that eventually affect normal cellular function [89]. In addition to 
direct invasion, microorganisms can release products into the circulation and induce 
pro-atherogenic responses in endothelial cells [90]. Research has highlighted that 
vesicles pertaining to the outer membrane such as gingipains from P. gingivalis and 
free soluble components deriving from A. actinomycetemcomitans cause irritation 
to endothelial cells and promote inflammation [91]. Effusion of pro-inflammatory 
cytokines (IL-1, IL-6 and TNF-α) and other chemokines from the affected peri-
odontal tissues leads to the generation of acute phase proteins (C reactive protein, 
fibrinogen, amyloid A, etc.) by the liver [92]. As a result of this injury, the activation 
of the adaptive immune system occurs as a typical response to chronic bacteraemia. 
Pathogen-associated molecular patterns (PAMPs) of periodontal pathogens deter-
mine the production of antibodies and elicit a cross-response between endothelial 
cells and the altered LDL to exacerbate the migration of lipids into cells inside the 
blood vessel walls [93]. Antigen-presenting cells, for example, dendritic cells and 
effector T lymphocytes, bear a substantial part in the generation of proatherogenic 
cytokines, for example, IL-20, IL-18 and IFN-γ, and are consequently also relevant 
in the progression of atherosclerotic plaques. A noteworthy role among the proath-
erogenic cytokines has been assigned to IL-12 due to the fact that when this certain 
molecule was absent early lesion development was inhibited. However, late progres-
sion was unaffected [94].
Considering the recent epidemiological, experimental and clinical evidence 
presented in the literature on this subject matter [86], the issue of an interrelation-
ship between periodontal disease and cardiovascular disease is clearly supported. In 
spite this, the exact nature of this relationship, whether it is a direct or causal one, 
remains to be edified through interventional and longitudinal studies.
4.4 Rheumatoid arthritis
Rheumatoid arthritis (RA) is considered to be an autoimmune, progressive, 
inflammatory and chronic disorder, in which the human immune system reacts in 
an erroneous manner to the articular structures. This response is characterised by 
an inflammatory immune cell infiltrate (activation of innate immunity, followed 
by the emergence of adaptive immune responses) in the early phase, followed by a 
destructive phase characterised by degenerative phenomena, such as denaturation 
of normal synovial structures by hyperproliferation, reactive fibro-vascular prolif-
eration, bone destruction and cartilage degradation. This explains the occurrence of 
swelling and pain within and around joints [95].
Over the past two decades, RA has been described as a disease model in which 
various pathophysiological mechanisms have been studied to better explain the 
inflammatory process, but also the modality of involvement of the human immune 
system, through two types of specific responses [95]. These research projects 
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culminated with the introduction into patients’ treatment regimens of the chimeric 
anti-TNF-α monoclonal antibodies (infliximab, 75% human and 25% mouse pep-
tide sequences) [96], a recombinant human TNF receptor (p75)–Fc fusion protein 
(etanercept) and biological therapy with fully human anti-TNF-α monoclonal 
antibodies [97].
Major cytokines, such as TNF-α and interleukins (IL-17 and IL-1β), function 
by promoting inflammatory responses, causing inflammation of the synovium 
and inducing cartilage degradation. Other soluble mediators, such as cytokines 
released by the Th2 lymphocyte subpopulation (the most frequently studied and 
for which statistically significant results were obtained, would be IL-4, IL-10, 
IL-13) are mainly anti-inflammatory molecules [95, 98]. In addition, IL-13 could 
have potential clinical importance because it can suppress both secretion and 
actions of IL-17 [98].
Over the past two decades, the existence of links or associations between RA 
and periodontitis has been investigated [99]. RA could be a triggering risk factor for 
periodontitis as there is a high incidence of RA in patients with periodontal disease, 
and RA patients have more chances to experience moderate to severe periodontal 
changes, as compared to healthy subjects. It has also been found that calcifications 
and soft tissue injuries have the same characteristics, leading to the conclusion that 
the destructive inflammatory chronic lesions are similar [100].
New theories have highlighted that periodontal disease is a risk factor for RA, 
with several similarities existing between RA and periodontitis [101–103]:
• both diseases are multifactorial, chronic immune-inflammatory diseases with 
progressive evolution;
• pathophysiological mechanisms involve the association of environmental fac-
tors, microbial factors, genetic susceptibility (it was found that the HLA-DRB1 
subtype is associated with both fast progressive periodontitis as well as RA);
• locally, the cellular composition of the inflammatory reactions is similar, it 
includes both the T and B subtypes of lymphocyte populations, but also the 
cells involved in the activation of lymphocytes such as dendritic cells;
• for both diseases, it was found that the changes occurring in early phases, as 
well as those in destructive phases are characterised by degenerative phenom-
ena and periodontal degradation, but also the chronic systemic inflammation is 
determined and mediated by the interruption of balance between the pro-
inflammatory and the anti-inflammatory cytokines; and
• change in connective tissue and bone homeostasis is irreversible, consisting 
in the deterioration of collagen-rich structures, a process in which they inten-
sively participate and have collagenolytic effects as matrix metalloproteinases 
and other enzymes (elastase, bacterial cysteine proteases, enzymes associated 
with neutrophils).
4.5 Liver diseases
One of the most damaging hepatic diseases is chronic hepatitis C (CHC), 
occurring after the infection with the hepatitis C virus (HCV), which replicates 
within hepatic and peripheral blood cells [104]. It is considered that worldwide, 
more than 200 million persons are affected by this disease, making it a major public 
health concern [105]. As the hepatic inflammation progresses and becomes chronic, 
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healthy liver tissue is replaced by fibrotic tissues, which is unable to perform normal 
hepatic functions, leading to cirrhosis [106]. During chronic hepatic inflamma-
tion important cytokine profile changes can be observed in affected patients, with 
increased levels of pro-inflammatory markers, such as TNF-α, being found in their 
serum samples [107].
Cytokine levels, measured in either gingival fluid or serum samples, can be 
used to assess the progression and severity of both periodontal and hepatic disease 
[108]. In periodontal disease, the secretion rate of gingival fluid increases, as well 
as its content in pro-inflammatory cytokines [109]. The levels of these cytokines 
can be determined, as an indirect indicator of the disease’s severity and progression 
rate [110]. Being easy to sample, the gingival fluid has allowed extensive research 
on its pro-inflammatory cytokine content [111]. Similarly, the evolution of chronic 
hepatitis C can be monitored by the assessment of some cytokine’s levels (such as 
IL-18 and IL-33) in the serum samples of affected patients [112, 113]. Moreover, 
the same pro-inflammatory cytokines, such as IL-1, Il-6 and interferon-gamma, 
can express elevated levels during chronic hepatic inflammation (as in chronic 
hepatitis C), as well as during chronic periodontal inflammation (as in chronic 
periodontal disease) [114]. The similar profiles of these cytokines suggest that 
the two inflammatory reactions could be driven by the same pro-inflammatory 
markers, endorsing extensive research on their possible common pathogenic 
mechanisms [108].
Another frequently encountered hepatic condition, particularly within developed 
regions, is non-alcoholic fatty liver disease (NAFLD). Affecting almost 24% of 
the global population [115], the disease is mainly caused by genetic or behavioural 
factors, such as a misbalanced diet, rich in lipids and sugars, lack of physical activ-
ity or can occur during other systemic conditions like obesity and diabetes mellitus 
[116]. The accumulation of fat leads to hepatic steatosis, which, in time, can develop 
life-threatening complications, as liver cirrhosis or hepatic cancer [117]. NAFLD has 
been associated with metabolic disorders, as insulin resistance [118], as the adipocytes 
of the fatty tissue will produce increased levels of TNF-α [119]. This cytokine can alter 
cellular sensitivity to insulin, therefore decreasing normal glucose metabolism. As a 
result, serum glucose will rise, increasing the risk of diabetes mellitus [118].
TNF-α is also intensively involved in periodontal inflammation. This cytokine has 
been shown to express increased levels in the gingival fluid of periodontal patients 
[120] and has similar pro-inflammatory mechanisms to IL-1β [121]. Its main damag-
ing role during periodontal inflammation is the disruption of the normal reparatory 
function of fibroblasts and the stimulation of bone-resorption osteoclasts [122]. 
TNF-α may represent a key cytokine that links the pathogenic mechanisms that are 
common between periodontal disease and insulin resistance, insulin resistance and 
NAFLD, and consequently between periodontal disease and NAFLD [123].
The relationship between periodontal disease and hepatic conditions could 
be considered as functioning into two directions. Firstly, periodontal disease can 
impact the development and outcome of hepatic conditions. The main explana-
tion of the root cause of the association between periodontal disease and hepatic 
conditions seems to be the bacterial challenge that leads to periodontal inflamma-
tion [124]. Pre-existing hepatic conditions, as chronic hepatitis, NAFLD or cirrhosis 
can be aggravated by the impact of bacterial attack on the periodontal tissues [125]. 
Important periodontal pathogens, like Porphyromonas gingivalis and Aggregatibacter 
actinomycetemcomitans stimulate the synthesis of pro-inflammatory cytokines by 
periodontal cells [126]. These cytokines, including TNF-α and IL-1 family ones, will 
be carried by the vascular system and reach the liver. Here, they can have damaging 
effects on the hepatocytes, if there is a pre-existing hepatic condition, by adding 
to the distress of the already impaired hepatic tissue [127]. Consequently, the liver 
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functions will be more difficult to perform and the conditions will aggravate, as a 
result of a bacterial periodontal challenge [128].
Conversely, hepatic conditions can impact the evolution and manifestations of 
periodontal disease, by means of increased cytokine production [129]. Various liver 
diseases, as NAFLD, CHC and liver cirrhosis, trigger the increased production of 
pro-inflammatory cytokines, including TNF-α, IL-1 family, IL-6, which also have 
a proven active role in the promoting of the periodontal inflammatory reaction 
[130]. These cytokines, originating from the affected hepatic tissue, enter the blood 
stream and reach the periodontal tissues. When a periodontal bacterial challenge 
occurs, they contribute to the exacerbation of the inflammatory reaction, inflict-
ing damage on the periodontal tissues, together with the periodontal-originating 
pro-inflammatory cytokines. Therefore, an exaggerated inflammatory response 
is triggered, causing important loss of periodontal structures in patients who also 
suffer from chronic liver diseases [131, 132].
4.6 Renal diseases
Chronic kidney disease (CKD) is an official public health concern, with 10–12% 
of the population affected in terms of mortality and morbidity [133, 134]. CKD 
is characterised by the use of certain markers that indicate the degree of kidney 
malfunction, notably the glomerular filtration rate (GFR), which indicates the kid-
ney’s functioning efficiency. CKD is diagnosed when multiple standard criteria are 
met, including a GFR lower than 60 mL/min, albumin levels higher than 30 mg/g 
of creatinine and the existence of morphological kidney changes. When the GFR 
drops below 15–20 mL/min, it can be considered that end-stage renal disease has 
occurred [135, 136].
Various harmful stimuli are triggers for inflammation, the physiological pro-
tecting mechanism of the body. In CKD, as in several other chronic debilitating 
disorders, inflammation becomes maladaptive, uncontrolled and persistent. In 
this group of patients, a majority of the patients with minimum Stage 3 CKD have 
increased levels of C-reactive protein (CRP) [137], this prevalence being even 
higher either in final stage CKD or in dialysis patients [138]. For the evaluation 
of inflammatory state in clinical practice, a series of specific markers are used. 
One of the most important inflammation indicators is the CRP, which can also be 
found in its high sensitive form (hs-CRP) in elevated levels in the serum samples of 
patients with chronic renal failure, along other pro-inflammatory cytokines [139]. 
Moreover, another pro-inflammatory cytokine, IL-6, could be a reliable indicator 
of the risk of cardiovascular diseases and mortality in subjects with end stage renal 
disease (ESRD) [140].
Malnutrition, a severe consequence of CKD, inflicts important changes in most 
ESRD patients, in terms of anthropometric and serologic aspects, most of which 
have an irreversible character, even with proper nutritional supplementation. In 
addition, malnutrition also comprises a chronic inflammatory reaction, driven by 
pro-inflammatory cytokines (IL-1, IL-6, TNF-α, IFN-γ, etc). This immune response 
can accelerate the muscular protein catabolism, on the one hand, by elevating the 
hepatic synthesis of positive acute phase proteins and, on the other hand, by sup-
pressing the production of negative acute phase proteins [141].
ESRD and haemodialysis (HD) itself lead to an inflammatory status, influ-
enced by numerous factors. The main factor of morbidity and mortality in dialysis 
patients is considered chronic inflammation, a major determinant of ‘dialysis 
syndrome’. Inflammation in dialysed patients is characterised by enhanced produc-
tion of CRP, TNF-α, IL-6, IL-2 and chemokines, such as IL-8, and it may vary over 
time and during this process [142].
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The bacteria of the subgingival biofilm can reach the systemic blood circula-
tory system, causing lesions to the arterial endothelium and triggering a series of 
pathogenic events that can eventually lead to atherosclerosis [85]. This mecha-
nism can explain certain pathogenic connections between local and systemic 
conditions. These connections may have a bidirectional nature, deriving from the 
similar local and systemic inflammatory reactions that these conditions manifest 
[143]. For instance, a renal inflammatory response (glomerulonephritis) can 
be triggered by various acute and chronic infections. This is supported by the 
increased prevalence of periodontal pathology in patients with renal diseases, 
suggesting the high relevance of the periodontal pathology in the onset of renal 
inflammatory responses [144].
Recently, research has focused on the contribution of inflammation, determined 
by periodontitis, to the overall inflammatory systemic burden in patients with CKD 
and dialysis. In this context, plasma levels of certain inflammatory cytokines may 
be relevant to malnutrition, morbidity and mortality of these patients, as well as to 
their quality of life [145]. Individuals with ESRD experience reduced quality of life 
and many of them also associate low oral health [145].
5. Conclusion
Through the intense implication of cytokines, the periodontal inflammatory 
reaction can exhibit a variety of clinical manifestations, in terms of onset, evolu-
tion, treatment and prognosis. The local and systemic factors, which can influence 
the development of periodontal inflammation, often have molecular and cellular 
implications, and cytokines become the means through which different pathologies 
can have mutual impact. The cytokine standpoint on periodontal disease and its 
connective systemic conditions offers wide and promising perspectives on further 
developments of more precise methods of diagnosis and more efficient therapeutic 
protocols.
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